NTSE-ACS for Professionals


In the United States, non–ST-elevation acute coronary syndromes (NSTE-ACS) affects more than 625,000 patients annually, or almost three fourths of all patients with ACS.

At presentation, patients with unstable angina (UA) and non–ST-elevation myocardial infarction (NSTEMI) can be difficult to distinguish.

Learn more about NSTE-ACS and ischemia-guided strategy approach to care and other critical information on NSTE-ACS.


Guidelines, Statements and Journal Articles


Non-ST Elevation Acute Coronary Syndrome (NSTE-ACS)

Dual Antiplatelet Therapy (DAPT)

News / New Studies


After a heart attack, one in four survivors call it quits
AHA News Article | October 4, 2017

Stopping daily aspirin increases heart attack, stroke risk
AHA News Article | September 25, 2017

First heart attacks more deadly for black patients
AHA News Article | July 10, 2017

A step closer to uncovering why women fare worse after heart attacks
AHA News Article | June 22, 2017

CME/CE Education


Non-ST-Elevation Acute Coronary Syndromes eBook: An Enhanced Overview of the AHA/ACC 2014 Guidelines
This multimedia e-book is designed to explain the evidence behind the ACS guidelines in an interactive, engaging manner, in order to improve the quality of care provided to your patients. It is built on the AHA/ACC 2014 Guidelines on the Management of Patients with Non–ST-Elevation Acute Coronary Syndromes.

NSTE-ACS: Insights from the 2014 AHA/ACC Guideline — Four Part Series
This four-part webinar series consists of cases, didactic presentations and discussions over the Non-ST Elevation Acute Coronary Syndrome (NSTE-ACS) Guideline. Participation in this program will provide you with additional resources to address recognition/risk factors, prevention/treatment, practice and guidelines for patients with NSTE-ACS.

Dual Antiplatelet Therapy — Part I
This activity provides a brief overview with facts on the importance of prescribing dual antiplatelet therapy to NSTEMI patients that meet criteria for this treatment.

Dual Antiplatelet Therapy — Part II
This activity is a continuation of Part I.

AHA Guidelines On-The-Go mobile App

Access the 2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients with Hypertrophic Cardiomyopathy and other guidelines on your mobile device anytime, anywhere! Download our free mobile app today and enjoy the benefits of staying up-to-date no matter where you are. Actionable at the point of care, users will be able to retrieve relevant pieces of content while also having access to additional support detail and evidence.

Acute Myocardial Infarction Toolkit

Use our tools and resources to empower your patients after a heart attack.
senior doctor with tablet working at the office

Online Learning

Expand your professional knowledge with online education from your home or office with our web-based activities.
  • Register for live CME/CE activities
  • Take on-demand CME/CE activities
  • Claim CME/CE for every AHA conference

American Heart Association Professional Members

Enjoy instant benefits!

  • Free Online Access to AHA Scientific Journals
  • Affiliate with our 16 Scientific Councils
  • Discounts on Scientific Conference Registration and Online Courses

Learn more about Professional Membership

This NSTE-ACS page for professionals is part of the Guidelines Transformation & Optimization Program and is supported by an educational grant from AstraZeneca. The American Heart Association’s Guideline Transformation & Optimization (GTO) Program is a comprehensive, coordinated approach to accelerate guidelines into clinical practice.

Visit www.heart.org/gto to learn more.